ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
10.31
-0.19 (-1.81%)
At close: Jun 27, 2025, 4:00 PM
10.40
+0.09 (0.87%)
After-hours: Jun 27, 2025, 7:47 PM EDT
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $878.66 million as of June 27, 2025. Its market cap has increased by 48.43% in one year.
Market Cap
878.66M
Enterprise Value
683.65M
1-Year Change
48.43%
Ranking
Category
Stock Price
$10.31
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $878.66M, an increase of 18.42%. That is a compound annual growth rate of 3.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 785.77M | 37.98% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | 1.24B | 67.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.02B |
| Johnson & Johnson | 365.12B |
| AbbVie | 329.38B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.69B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.17B |
| AstraZeneca | 216.45B |